Up a level |
Khoury, Joseph D, Solary, Eric, Abla, Oussama, Akkari, Yassmine, Alaggio, Rita, Apperley, Jane F, Bejar, Rafael, Berti, Emilio, Busque, Lambert, Chan, John KC et al (show 52 more authors)
(2022)
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.
LEUKEMIA, 36 (7).
pp. 1703-1719.
Khoury, Joseph D, Solary, Eric, Abla, Oussama, Akkari, Yassmine, Alaggio, Rita, Apperley, Jane F, Bejar, Rafael, Berti, Emilio, Busque, Lambert, Chan, John KC et al (show 52 more authors)
(2022)
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.
LEUKEMIA, 36 (7).
pp. 1703-1719.
Khoury, Joseph D, Solary, Eric, Abla, Oussama, Akkari, Yassmine, Alaggio, Rita, Apperley, Jane F, Bejar, Rafael, Berti, Emilio, Busque, Lambert, Chan, John KC et al (show 52 more authors)
(2022)
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.
LEUKEMIA, 36 (7).
pp. 1703-1719.
Khoury, Joseph D, Solary, Eric, Abla, Oussama, Akkari, Yassmine, Alaggio, Rita, Apperley, Jane F, Bejar, Rafael, Berti, Emilio, Busque, Lambert, Chan, John KC et al (show 52 more authors)
(2022)
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.
LEUKEMIA, 36 (7).
pp. 1703-1719.
Clark, Richard E ORCID: 0000-0002-1261-3299, Apperley, Jane F, Copland, Mhairi and Cicconi, Silvia
(2021)
Additional chromosomal abnormalities at chronic myeloid leukemia diagnosis predict an increased risk of progression.
BLOOD ADVANCES, 5 (4).
pp. 1102-1109.
Patel, Amit ORCID: 0000-0003-0029-4611, Szydlo, Richard M ORCID: 0000-0003-1102-8298, Auner, Holger W ORCID: 0000-0003-4040-0642, Kanfer, Edward J, MacDonald, Donald H, Milojkovic, Dragana, Altaf, Syed, Innes, Andrew, Gabriel, Ian, Rahemtulla, Amin et al (show 5 more authors)
(2018)
C-reactive protein prior to myeloablative allogeneic haematopoietic cell transplantation identifies patients at risk of early- and long-term mortality.
British journal of haematology, 180 (6).
pp. 889-892.
Clark, Richard E ORCID: 0000-0002-1261-3299, Polydoros, Fotios ORCID: 0000-0001-5181-6817, Apperley, Jane F, Milojkovic, Dragana, Pocock, Christopher, Smith, Graeme, Byrne, Jenny L, de lavallade, Hugues, O'Brien, Stephen G, Coffey, Tony et al (show 2 more authors)
(2017)
De-escalation of tyrosine kinase inhibitor dose in patients with chronic myeloid leukaemia with stable major molecular response (DESTINY): an interim analysis of a non-randomised, phase 2 trial.
The Lancet Haematology, 4 (7).
E310-E316.
Clark, Richard E ORCID: 0000-0002-1261-3299, Polydoros, Fotios, Apperley, Jane F, Milojkovic, Dragana, Rothwell, Katherine, Pocock, Christopher, Byrne, Jennifer, de lavallade, Hugues, Osborne, Wendy, Robinson, Lisa et al (show 4 more authors)
(2019)
De-escalation of tyrosine kinase inhibitor therapy before complete treatment discontinuation in patients with chronic myeloid leukaemia (DESTINY): a non-randomised, phase 2 trial.
The Lancet Haematology, 6 (7).
E375-E383.
Claudiani, Simone, Apperley, Jane F, Gale, Robert Peter, Clark, Richard ORCID: 0000-0002-1261-3299, Szydlo, Richard ORCID: 0000-0003-1102-8298, Deplano, Simona, Palanicawandar, Renuka, Khorashad, Jamshid, Foroni, Letizia and Milojkovic, Dragana
(2017)
E14a2 <i>BCR-ABL1</i> transcript is associated with a higher rate of treatment-free remission in individuals with chronic myeloid leukemia after stopping tyrosine kinase inhibitor therapy.
Haematologica, 102 (8).
e297-e299.
Clark, Richard E ORCID: 0000-0002-1261-3299, Basabrain, Ammar A, Austin, Gemma M, Holcroft, Alison K, Loaiza, Sandra, Apperley, Jane F, Law, Christopher, Scott, Laura, Parry, Alexandra D, Bonnett, Laura ORCID: 0000-0002-6981-9212 et al (show 1 more authors)
(2021)
Validation of CIP2A as a Biomarker of Subsequent Disease Progression and Treatment Failure in Chronic Myeloid Leukaemia.
CANCERS, 13 (9).
2155-.
Claudiani, Simone, Janssen, Jeroen JWM, Byrne, Jenny, Smith, Graeme, Blijlevens, Nicole, Raghavan, Manoj, Smith, Matthew, Clark, Richard E ORCID: 0000-0002-1261-3299, Mclain-Smith, Susan, Carter, Angela M et al (show 2 more authors)
(2022)
A retrospective observational research study to describe the real-world use of bosutinib in patients with chronic myeloid leukemia in the United Kingdom and the Netherlands.
EUROPEAN JOURNAL OF HAEMATOLOGY, 109 (1).
pp. 90-99.